AIMC Topic: Molecular Typing

Clear Filters Showing 1 to 3 of 3 articles

A Molecular Typing Method for Invasive Breast Cancer by Serum Raman Spectroscopy.

Clinical breast cancer
BACKGROUND: The incidence of breast cancer ranks highest among cancers and is exceedingly heterogeneous. Immunohistochemical staining is commonly used clinically to identify the molecular subtype for subsequent treatment and prognosis.

A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.

Breast cancer research : BCR
BACKGROUND: Breast cancer intrinsic molecular subtype (IMS) as classified by the expression-based PAM50 assay is considered a strong prognostic feature, even when controlled for by standard clinicopathological features such as age, grade, and nodal s...

Identification and transfer of spatial transcriptomics signatures for cancer diagnosis.

Breast cancer research : BCR
BACKGROUND: Distinguishing ductal carcinoma in situ (DCIS) from invasive ductal carcinoma (IDC) regions in clinical biopsies constitutes a diagnostic challenge. Spatial transcriptomics (ST) is an in situ capturing method, which allows quantification ...